ACAD
ACADIA Pharmaceuticals Inc
27.30$
-0.6%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 77,620.0% | 4,098.4% | 25.4% | 10.5% | 8.2% | 5.8% | 4.7% | 4.0% | 2.0% | 6.3% | 8.5% | 8.3% | |
| 100.0% | 100.0% | 74.6% | 89.5% | 91.8% | 94.2% | 95.3% | 96.0% | 98.0% | 93.7% | 91.5% | 91.7% | |
| 50,501.7% | 121,096.7% | 572.9% | 119.4% | 83.6% | 70.9% | 72.2% | 49.5% | 69.9% | 48.4% | 31.7% | 30.7% | |
| 27,290.0% | 148,859.0% | 1,075.9% | 204.2% | 118.7% | 96.0% | 88.0% | 81.8% | 71.4% | 54.1% | 51.0% | 51.2% | |
| 77,791.7% | 269,955.7% | 1,648.7% | 323.7% | 202.4% | 166.9% | 160.2% | 131.3% | 141.3% | 103.8% | 67.4% | 81.9% | |
| -77,691.7% | -269,855.7% | -1,574.1% | -234.1% | -110.6% | -72.7% | -64.9% | -35.2% | -43.2% | -10.1% | 24.1% | 9.8% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 4.4% | 1.9% | 1.3% | 1.3% | – | – | – | |
| -77,062.5% | -269,037.7% | -1,558.2% | -230.8% | -109.0% | -69.1% | -63.6% | -34.6% | -41.3% | -7.0% | 26.9% | 13.0% | |
| -171.7% | 541.0% | 7.7% | 0.9% | 0.6% | 0.3% | 0.1% | 0.1% | 0.5% | 1.4% | 3.3% | -23.5% | |
| -77,062.5% | -269,578.7% | -1,565.9% | -231.7% | -109.6% | -69.4% | -63.7% | -34.7% | -41.8% | -8.4% | 23.6% | 36.5% | |
| -77,520.0% | -268,795.1% | -1,563.6% | -231.9% | -109.2% | -71.9% | -64.2% | -34.5% | -42.8% | -6.3% | 10.5% | 14.1% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.